Skip to main content
SpringerLink
Log in

Chronic Bacterial Prostatitis

  • Chapter
Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Part of the book series: Current Clinical Urology ((CCU))

Summary

In only about 10% of men with symptoms of chronic prostatitis/chronic pelvic pain syndrome can bacterial infection of the prostate be demonstrated by the Meares & Stamey 4-glass or the pre and post prostate massage (PPM) 2-glass test. Chronic bacterial prostatitis is mainly caused by Gram-negative uropathogens. The role of Gram-positives, such as staphylococci and enterococci, and atypicals, such as chlamydia, ureaplasmas, mycoplasmas, are still debatable. For treatment, fluoroquinolones are considered the drugs of choice because of their favorable pharmacokinetic properties and their antimicrobial spectrum. Because relapse and reinfection are major problems in chronic bacterial prostatitis, only the results of studies with a follow-up period of at least 6 months are meaningful. Analyzing the concentrations of various fluoroquinolones in prostatic and seminal fluid as well as in prostatic tissue, however, it becomes obvious that the fluoroquinolones differ not only in plasma concentrations but also in their penetration ability to these sites. Nevertheless, overall the concentrations at the site of infection of most of the fluoroquinolones with this indication should be sufficient for the treatment of chronic bacterial prostatitis and vesiculitis caused by highly susceptible pathogens. However, the increasing resistance of Escherichia coli, the most frequent uropathogens, against fluoroquinolones in many countries is of great concern.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Schaeffer, A. J. (1999) Prostatitis: US perspective. Int. J. Antimicrob. Agents 11, 205–11; discussion 13–16.

    Article  PubMed  CAS  Google Scholar 

  2. Krieger, J. N., Nyberg L, Jr., and Nickel, J. C. (1999) NIH consensus definition and classification of prostatitis. JAMA 282, 236–237.

    Article  PubMed  CAS  Google Scholar 

  3. Calhoun EA MR, O'Keeffe-Rosetti M, Gao S, Brown S, and Clemens, J. Q. (2005) Prevalence of prostatitis-like symptoms in a managed care population. In: American Urological Association Annual Meeting; 2005; San Antonio.

    Google Scholar 

  4. Clemens JQ MR, O'Keeffe-Rosetti M, Gao, S. Y., and Calhoun, E. A. (2005) Incidence and clinical characteristics of NIH type III prostatitis in a managed care population, in American Urological Association Annual Meeting; 2005; San Antonio.

    Google Scholar 

  5. Weidner W, Schiefer, H. G., Krauss H, Jantos C, Friedrich, H. J., and Altmannsberger, M. (1991) Chronic prostatitis: A thorough search for etiologically involved microorganisms in 1,461 patients. Infection 19(Suppl 3), S119–S125.

    Article  PubMed  Google Scholar 

  6. Krieger, J. N., and McGonagle, L. A. (1989) Diagnostic considerations and interpretation of microbiological findings for evaluation of chronic prostatitis. J. Clin. Microbiol. 27, 2240–2244.

    PubMed  CAS  Google Scholar 

  7. Bundrick W, Heron, S. P., Ray P, et al. (2003) Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: A randomized double-blind multicenter study. Urology 62, 537–541.

    Article  PubMed  Google Scholar 

  8. Nickel JC ZN, Spivey M, and Wu, S. C. (2005) Clinical significance of antimicrobial therapy in chronic prostatitis associated with non-traditional uropathogens. In: American Urological Association Annual Meeting; 2005; San Antonio.

    Google Scholar 

  9. Riley DE RS, Limaye, A. P., and Krieger, J. N. (2005) Inconsistent localization of Gram-positive bacteria to prostate-specific specimens from patients with chronic prostatitis. In: American Urological Association Annual Meeting; 2005; San Antonio.

    Google Scholar 

  10. Meares, E. M., and Stamey, T. A. (1968) Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest. Urol. 5, 492–518.

    PubMed  CAS  Google Scholar 

  11. Schneider H, Ludwig M, Hossain, H. M., Diemer T, and Weidner, W. (2003) The 2001 Giessen Cohort Study on patients with prostatitis syndrome—an evaluation of inflammatory status and search for microorganisms 10 years after a first analysis. Andrologia 35, 258–262.

    PubMed  CAS  Google Scholar 

  12. Nickel, J. C., Shoskes D, Wang Y, et al. (2006) How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J. Urol. 176, 119–124.

    Article  PubMed  Google Scholar 

  13. Weidner W, Ludwig M, Brahler E, and Schiefer, H. G. (1999) Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis. Drugs 58(Suppl 2), 103–106.

    Article  PubMed  CAS  Google Scholar 

  14. Stamey, T. A., Meares, E. M., Jr., and Winningham, D. G. (1970) Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J. Urol. 103, 187–194.

    PubMed  CAS  Google Scholar 

  15. Stamey, T. A., Bushby, S. R., and Bragonje, J. (1973) The concentration of trimethoprim in prostatic fluid: nonionic diffusion or active transport? J. Infect. Dis. 128(Suppl):686–689.

    PubMed  Google Scholar 

  16. Madsen, P. O., Kjaer, T. B., and Baumueller, A. (1976) Prostatic tissue and fluid concentrations of trimethoprim and sulfamethoxazole: Experimental and clinical studies. Urology 8, 129–132.

    Article  PubMed  CAS  Google Scholar 

  17. Gasser T, Larsen, E. H., Dorflinger, T, and Madsen, P. O. (1986) The influence of various body fluids and pH on, E. coli MIC of quinolone derivatives, Weidner W (ed): Therapy of Prostatitis: Experimental and Clinical Data. Zuckschwerdt, Munich, 1986, pp. 50–53.

    Google Scholar 

  18. Sörgel F, Bulitta, J, and Kinzig-Schippers, M. (2002) Pharmakokinetik der Chinolone. Chemother. J. (Suppl 20), 25–33.

    Google Scholar 

  19. Naber, K. G., Kinzig M, Sorgel F, and Weigel, D. (1993) Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid. Infection 21, 98–100.

    Article  PubMed  CAS  Google Scholar 

  20. Naber, K. G., Sorgel F, Kinzig M, and Weigel, D. M. (1993) Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg. J. Urol. 150, 1718–1721.

    PubMed  CAS  Google Scholar 

  21. Naber, C. K., Steghafner M, Kinzig-Schippers M, et al. (2001) Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers. Antimicrob. Agents Chemother. 45, 293–297.

    Article  PubMed  CAS  Google Scholar 

  22. Naber, K. (1993) Role of quinolones in treatment of chronic bacterial prostatitis, in Hooper DC WJ (ed): Quinolone Antimicrobial Agents. American Society of Microbiology, Washington, DC, 1993, pp. 285–297.

    Google Scholar 

  23. Sörgel F, Kinzig, M, and Naber, KG. (1993) Physiological disposition of macrolides, in Bryskier, A., Butzler, J.-P., Neu, H. C., Tulkens, P. M., (ed): Macrolides Chemistry, Pharmacology and Clinical Uses. Arnette Blackwell, Paris, 199, pp. 421–431.

    Google Scholar 

  24. Blacklock, N. J., Beavis, J. P. (1974) The response of prostatic fluid pH in inflammation. Br. J. Urol. 46, 537–542.

    Article  PubMed  CAS  Google Scholar 

  25. Kavanagh, J. P., Darby C, and Costello, C. B. (1982) The response of seven prostatic fluid components to prostatic disease. Int. J. Androl. 5, 487–496.

    Article  PubMed  CAS  Google Scholar 

  26. Pfau, A., Perlberg, S., and Shapira, A. (1978) The pH of the prostatic fluid in health and disease: implications of treatment in chronic bacterial prostatitis. J. Urol. 119, 384–387.

    PubMed  CAS  Google Scholar 

  27. White, M. A. (1975) Change in pH of expressed prostatic secretion during the course of prostatitis. Proc. R. Soc. Med. 68, 511–513.

    PubMed  CAS  Google Scholar 

  28. Naber, K. G., and Giamarellou, H. (1994) Proposed study design in prostatitis. Infection 22(Suppl 1), S59–S60.

    Article  PubMed  Google Scholar 

  29. Pust, R. A., Ackenheil-Koppe, H. R., Gilbert P, and Weidner, W. (1989) Clinical efficacy of ofloxacin (tarivid) in patients with chronic bacterial prostatitis: preliminary results. J. Chemother. 1(4 Suppl), 869–871.

    PubMed  CAS  Google Scholar 

  30. Weidner W, Schiefer, H. G., and Dalhoff, A. (1987) Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study. Am. J. Med. 82, 280–283.

    PubMed  CAS  Google Scholar 

  31. Weidner W, Schiefer, H. G., and Brahler, E. (1991) Refractory chronic bacterial prostatitis: A re-evaluation of ciprofloxacin treatment after a median followup of 30 months. J. Urol. 146, 350–352.

    PubMed  CAS  Google Scholar 

  32. Pfau, A. (1991) The treatment of chronic bacterial prostatitis. Infection 19(Suppl 3):S160–S164.

    Article  PubMed  Google Scholar 

  33. Schaeffer, A. J., and Darras, F. S. (1990) The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin. J. Urol. 144, 690–693.

    PubMed  CAS  Google Scholar 

  34. Naber, K. G., Busch W, and Focht, J. (2000) Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group. Int. J. Antimicrob. Agents 14, 143–149.

    Article  PubMed  CAS  Google Scholar 

  35. Naber, K. G. (2002) Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis. Int. J. Antimicrob. Agents 20, 18–27.

    Article  PubMed  CAS  Google Scholar 

  36. Naber, K. G., Bergman B, Bishop, M. C., et al. (2001) EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur. Urol. 40, 576–588.

    Article  PubMed  CAS  Google Scholar 

  37. Barbalias, G. A., Nikiforidis, G., and Liatsikos, E. N. (1998) Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J. Urol. 159, 883–887.

    Article  PubMed  CAS  Google Scholar 

  38. Smith, J. W., Jones, S. R., Reed, W. P., Tice, A. D., Deupree, R. H., and Kaijser, B. (1979) Recurrent urinary tract infections in men. Characteristics and response to therapy. Ann. Intern. Med. 91, 544–548.

    PubMed  CAS  Google Scholar 

  39. Biering-Sorensen, F., Hoiby, N., Nordenbo, A., Ravnborg, M., Bruun, B., and Rahm, V. (1994) Ciprofloxacin as prophylaxis for urinary tract infection: Prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. J. Urol. 151, 105–108.

    PubMed  CAS  Google Scholar 

  40. van der Wall E, Verkooyen, R. P., Mintjes-de Groot J, et al. (1992) Prophylactic ciprofloxacin for catheter-associated urinary-tract infection. Lancet 339, 946–951.

    Article  PubMed  Google Scholar 

  41. Drlica, K., and Zhao, X. (1997) DNA gyrase, topoisomerase I, V, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61, 377–392.

    PubMed  CAS  Google Scholar 

  42. Naber, K. G., and Sorgel, F. (2003) Antibiotic therapy—rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue. Andrologia 35, 331–335.

    PubMed  CAS  Google Scholar 

  43. Bulitta, J., Kinzig-Schippers, M., Naber, C. K., Naber, K. G., Sauber, S., Kleinschnitz, M., Wahode, H., Rodamer, M., and Soergel, F. Limitations in the use of drug cocktails to compare the pharmacokinetics of drugs: ciprofloxacin vs levofloxacin, in Asf (ed): Microbiology. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Toronto, 2000. p. 506.

    Google Scholar 

  44. Farker K, Naber, K. G., and Funfstuck, R. (2001) [Fluoroquinolones: utilization in renal and urogenital tract infections]. Med. Klin. (Munich) 96, 383–390.

    CAS  Google Scholar 

  45. Wagenlehner F. M. E., Kees F., Weidner W., Wagenlehner C., and Naber K. G. (2007) Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following singe oral administration of 400 mg to healthy volunteers. Int. J. Antimicrob. Agents, in press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinic for Urology and Pediatric Urology, Justus-Liebig-University, Giessen, Germany

    Wolfgang Weidner & Florian M. E. Wagenlehner

  2. Urology Clinic, St. Elisabeth Hospital, Straubing, Germany

    Kurt G. Naber

Authors
  1. Wolfgang Weidner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Florian M. E. Wagenlehner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kurt G. Naber
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, Ohio

    Daniel A. Shoskes MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Weidner, W., Wagenlehner, F.M., Naber, K.G. (2008). Chronic Bacterial Prostatitis. In: Shoskes, D.A. (eds) Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-59745-472-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-472-8_3

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-934115-27-5

  • Online ISBN: 978-1-59745-472-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation